Cardiovascular risk in aging and obesity: is there a role for GH. (Q36309188)

13 August 2017

1 reference

title

Cardiovascular risk in aging and obesity: is there a role for GH. (English)

1 reference

13 August 2017

Gola M

1

1 reference

13 August 2017

Bonadonna S

2

1 reference

13 August 2017

Doga M

3

1 reference

13 August 2017

Mazziotti G

4

1 reference

13 August 2017

Giustina A

5

1 reference

13 August 2017

publication date

1 September 2005

1 reference

Journal of Endocrinological Investigation

13 August 2017

published in

1 reference

13 August 2017

volume

28

1 reference

13 August 2017

issue

8

1 reference

13 August 2017

page(s)

759-767

1 reference

Clinical aspects of growth hormone deficiency in adults

13 August 2017

cites work

1 reference

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group

21 January 2018

1 reference

Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease

21 January 2018

1 reference

Vascular insulin/insulin-like growth factor-1 resistance in female obese Zucker rats

21 January 2018

1 reference

Characterization of the insulin resistance of aging

21 January 2018

1 reference

Influence of aging on hepatic and peripheral glucose metabolism in humans

21 January 2018

1 reference

Effects of ageing on insulin secretion and action

21 January 2018

1 reference

Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men.

21 January 2018

1 reference

Ageing and longevity are related to growth hormone/insulin-like growth factor-1 secretion

21 January 2018

1 reference

The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study

21 January 2018

1 reference

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women

21 January 2018

1 reference

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release

21 January 2018

1 reference

Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.

21 January 2018

1 reference

Repetitive growth hormone-releasing hormone administration restores the attenuated growth hormone (GH) response to GH-releasing hormone testing in normal aging

21 January 2018

1 reference

Contributions of gender and systemic estradiol and testosterone concentrations to maximal secretagogue drive of burst-like growth hormone secretion in healthy middle-aged and older adults

21 January 2018

1 reference

Age and secretagogue type jointly determine dynamic growth hormone responses to exogenous insulin-like growth factor-negative feedback in healthy men.

21 January 2018

1 reference

Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man.

21 January 2018

1 reference

Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity

21 January 2018

1 reference

Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects.

21 January 2018

1 reference

Neuroendocrine and Metabolic Effects of Acute Ghrelin Administration in Human Obesity

21 January 2018

1 reference

Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients

21 January 2018

1 reference

Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency

21 January 2018

1 reference

Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency

21 January 2018

1 reference

Growth hormone, body composition, and aging

21 January 2018

1 reference

Effects of human growth hormone in men over 60 years old

21 January 2018

1 reference

Growth hormone replacement in healthy older men improves body composition but not functional ability

21 January 2018

1 reference

Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men.

21 January 2018

1 reference

Short-term treatment with low doses of recombinant human GH stimulates lipolysis in visceral obese men.

21 January 2018

1 reference

Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity

21 January 2018

1 reference

Clinical review: Growth hormone and cardiovascular risk factors

21 January 2018

1 reference

Mechanisms of Insulin Resistance in Aging

21 January 2018

1 reference

12 December 2020

Beneficial effect on average lipid levels from energy restriction and fat loss in obese individuals with or without type 2 diabetes

1 reference

12 December 2020

Effects of growth hormone administration on protein dynamics and substrate metabolism during 4 weeks of dietary restriction in obese women

1 reference

12 December 2020

Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

1 reference

12 December 2020

Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism.

1 reference

12 December 2020

Human growth hormone and human aging

1 reference

12 December 2020

Aging, Total Body Potassium, Fat-free Mass, and Cell Mass in Males and Females Between Ages 18 and 85 Years

1 reference

12 December 2020

The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals

1 reference

12 December 2020

Effects of short term administration of recombinant human growth hormone to elderly people

1 reference

12 December 2020

Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity

1 reference

12 December 2020

Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supp

1 reference

12 December 2020

A Preliminary Study of Growth Hormone in the Treatment of Dilated Cardiomyopathy

1 reference

12 December 2020

The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women

1 reference

12 December 2020

Recombinant human insulin-like growth factor-I increases forearm blood flow

1 reference

12 December 2020

Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy

1 reference

12 December 2020

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

12 December 2020

Mechanism of action of hexarelin and GHRP-6: analysis of the involvement of GHRH and somatostatin in the rat

1 reference

12 December 2020

Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus.

1 reference

12 December 2020

Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women.

1 reference

12 December 2020

Cerebrospinal fluid and plasma concentrations of SRIH, beta-endorphin, CRH, NPY and GHRH in obese and normal weight subjects

1 reference

12 December 2020

Persistent lipolytic effect of exogenous growth hormone during caloric restriction

1 reference

12 December 2020

Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.

1 reference

12 December 2020

Growth hormone treatment in aging: state of the art and perspectives

1 reference

12 December 2020

Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure

1 reference

12 December 2020

Human aging and the GH-IGF-I axis.

1 reference

12 December 2020

Repetitive GHRH administration fails to increase the response to GHRH in obese subjects. Evidence for a somatotrope defect in obesity?

1 reference

12 December 2020

Epidemiology of diabetes mellitus in the elderly. The Framingham Study

1 reference

12 December 2020

Comparative Effect of Galanin and Pyridostigmine on the Growth Hormone Response to Growth Hormone-Releasing Hormone in Normal Aged Subjects

1 reference

12 December 2020

Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients

1 reference

12 December 2020

Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess

1 reference

12 December 2020

Obesity and the heart

1 reference

12 December 2020

Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.

1 reference

12 December 2020

Haemodynamic effects of intravenous growth hormone in congestive heart failure

1 reference

12 December 2020

Effects of Human Growth Hormone, Insulin-Like Growth Factor I, and Diet and Exercise on Body Composition of Obese Postmenopausal Women1

1 reference

12 December 2020

Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects

1 reference

12 December 2020

Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin

1 reference

12 December 2020

Growth hormone and hepatic lipoprotein metabolism

1 reference

12 December 2020

Growth hormone in obesity

1 reference

12 December 2020

Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults

1 reference

12 December 2020

Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women

1 reference

12 December 2020

Sustained growth hormone (GH) and insulin-like growth factor I responses to prolonged high-dose twice-daily GH-releasing hormone stimulation in middle-aged and older men

1 reference

12 December 2020

Adult lean body mass declines with age: some longitudinal observations

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03347561

1 reference

13 August 2017

1 reference